Proteocypher is a company which provides analytical services to the hospital clinician so that use of high cost drugs can be rationalised. We enable cost-benefit decisions to be made with confidence by clinicians.
We specialise in assessing the global protein expression profiles of blood, body fluid and tissue biopsy samples from patients with a range of autoimmune diseases, in particular arthritis.
Our services present a major cost saving opportunity to health trusts and ultimately the tax payer. Our analytical technology can also provide more complete evidence of treatment effects and safety in clinical studies than is currently possible.